The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor
Authors
Keywords
-
Journal
BLOOD
Volume 142, Issue 18, Pages 1556-1569
Publisher
American Society of Hematology
Online
2023-08-26
DOI
10.1182/blood.2023020622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- (2023) Connie W. Tsao et al. CIRCULATION
- Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition
- (2023) Stephanie A. Renna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19
- (2022) Jan Zlamal et al. Blood Advances
- Diagnosis and Treatment of Pulmonary Arterial Hypertension
- (2022) Nicole F. Ruopp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD
- (2022) Martin Kolb et al. ADVANCES IN THERAPY
- Dual Antiplatelet Therapy Is Associated with Increased Risk of Bleeding and Decreased Risk of Stroke Following Carotid Endarterectomy
- (2022) Rohini J. Patel et al. ANNALS OF VASCULAR SURGERY
- A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action
- (2021) Roger G. Biringer Journal of Cell Communication and Signaling
- Platelet ACKR3/CXCR7 Favors Anti-Platelet Lipids over an Atherothrombotic Lipidome and Regulates Thrombo-inflammation
- (2021) Malgorzata Cebo et al. BLOOD
- Therapeutic strategies for thrombosis: new targets and approaches
- (2020) Nigel Mackman et al. NATURE REVIEWS DRUG DISCOVERY
- Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient
- (2020) Ziqing Li et al. Acta Physiologica
- International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions
- (2020) Xavier Norel et al. PHARMACOLOGICAL REVIEWS
- A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action
- (2020) Roger G. Biringer Journal of Cell Communication and Signaling
- Omega-6 DPA and its 12-lipoxygenase–oxidized lipids regulate platelet reactivity in a nongenomic PPARα-dependent manner
- (2020) Jennifer Yeung et al. Blood Advances
- DHA 12‐LOX‐derived oxylipins regulate platelet activation and thrombus formation through a PKA‐dependent signaling pathway
- (2020) Adriana Yamaguchi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice
- (2020) Hongliang He et al. Science Advances
- Utility of thromboelastography for the diagnosis of von Willebrand disease
- (2019) Katherine Regling et al. PEDIATRIC BLOOD & CANCER
- Selective Prostacyclin Receptor Agonist Selexipag, in Contrast to Prostacyclin Analogs, Does Not Evoke Paradoxical Vasoconstriction of the Rat Femoral Artery
- (2018) Keith Morrison et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
- (2018) Jennifer Yeung et al. PHARMACOLOGICAL REVIEWS
- Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice
- (2017) Etheresia Pretorius et al. THROMBOSIS RESEARCH
- 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via GαsSignaling in PlateletsHighlights
- (2016) Jennifer Yeung et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy
- (2016) Y. Arima et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation
- (2016) V. L. Serebruany et al. THROMBOSIS AND HAEMOSTASIS
- Mechanism of Race-Dependent Platelet Activation Through the Protease-Activated Receptor-4 and Gq Signaling Axis
- (2014) Benjamin E. Tourdot et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Off-target effects of glycoprotein IIb/IIIa receptor inhibitors
- (2014) Małgorzata Ostrowska et al. Cardiology Journal
- Plasma fibronectin supports hemostasis and regulates thrombosis
- (2014) Yiming Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Prostacyclin Receptor Regulation --- from Transcription to Trafficking
- (2012) C. Midgett et al. CURRENT MOLECULAR MEDICINE
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
- (2012) Marie-Luise von Brühl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation
- (2012) Kenneth N. Ikei et al. JOURNAL OF LIPID RESEARCH
- A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions
- (2011) K. HOSOKAWA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search